A laboratory test — or assay — developed in Sudbury, Ont., to measure the effectiveness of chemotherapy is one step closer to becoming commercially available.

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

I was diagnosed with cholangiocarcinoma, or cancer of the bile duct. As far as cancers go, it’s an especially brutal one: The five-year survival rate is around 10 percent, and most people diagnosed ...

An architect attributed his headaches to "work stress" - until a seizure uncovered the devastating reality. Craig Alexander, then 35, had endured headaches and dizziness for years, which he blamed on ...

'One moment I was working, travelling and living my life as normal, and the next I was facing major brain surgery.' ...

Redcar nurse Steve Lamb put his migraines down to work stress from 12-hour shifts, but was then diagnosed with terminal brain ...

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

An architect put his headaches down to "work stress" - until a seizure revealed the devastating truth. Craig Alexander, then 35, had suffered with headaches and dizziness for years, which he put down ...

An architect put his headaches down to “work stress” – until a seizure revealed he had a brain tumour. Craig Alexander, then 35, had suffered with headaches and dizziness for years, which he put down ...

In the fall of 2022, when I was 42 and living with my wife and three young kids in a small town in northwest Minnesota, a specialist at an unfamiliar hospital approached us with some test results. He ...

A nurse who put his migraines down to work stress from 12 hour shifts was later diagnosed with terminal brain cancer. Steve Lamb, 46, turned out to have a grade four glioblastoma brain tumour after he ...

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.